- $124.12m
- $112.05m
- $7.01m
Brief: Sharps Technology Files For Mixed Shelf Offering Of Up To $200 Million - SEC Filing
Brief: Sharps Technology Received Notice from Nasdaq that It Was Not In Compliance With A Listing Rule
Brief: Sharps Technology Provides Update On Commercialization Activities And Is Highlighted In Med Tech Outlook Feature Article
Brief: Sharps Technology Ships First Containers Of Safety Syringes To Nephron Pharmaceuticals For Commercialization
Brief: Sharps Technology Inc To Introduce New Specialized Prefillable Syringe Systems In 2023
Brief: Sharps Technology Begins Manufacturing At Its Hungary Facility
Brief: Sharps Technology, Nephron Pharmaceuticals Signs Distribution Agreement
Brief: Nephron Pharmaceuticals Corporation And Sharps Technology Inc Announce Manufacturing And Research Partnership
NASDAQ RESUMED AT 11:11 AM
NASDAQ RESUMED AT 11:11 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
Brief: Sharps Technology Announces Pricing Of Initial Public Offering